Enrico M. Novelli, MD, is a classical (benign) hematologist, the Chief of the Section of Benign Hematology, and the medical director of the UPMC Adult Sickle Cell Disease Program. Board-certified in hematology, Dr. Novelli received his medical degree from the University of Milan, Italy. He completed his residency in internal medicine and fellowship in hematology-oncology at UPMC. Dr. Novelli specializes in sickle cell anemia and hemoglobinopathies. Dr. Novelli is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease. Dr. Hillery is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Julia Xu is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Xu is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Hemoglobinopathy, Congenital Hemolytic Anemia, Sickle Cell Disease, and Hemolytic Anemia. Dr. Xu is currently accepting new patients.

Melissa K. Yee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center.  She specializes in the treatment of solid tumors and blood disorders. Dr. Yee is board-certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.  She received her medical degree from the Drexel University College of Medicine in Philadelphia. She then completed her internal medicine residency and hematology/oncology fellowship at UPMC. She earned her undergraduate degree from Tufts University. After completion of her medical training, she was on staff at Dana Farber Cancer Institute in Boston before returning to Pittsburgh to practice at UPMC Mercy. Dr. Yee is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology, and Massachusetts Medical Society. Dr. Yee is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma.

Craig Seaman is a Hematologist in Pittsburgh, Pennsylvania. Dr. Seaman is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Von Willebrand Disease (VWD), Hemophilia A, Blood Clots, and Hemophilic Arthropathy. Dr. Seaman is currently accepting new patients.

Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology. He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital. Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia. Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals. View the full list of Dr. Kalpatthi’s publications on PubMed. Dr. Kalpatthi is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.

James Cooper, MD, MSc, is clinical director of the Coagulation Program at UPMC Children's Hospital of Pittsburgh. He is also an assistant professor of pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology and pediatrics. Dr. Cooper earned his medical degree from University of Connecticut School of Medicine. He completed a residency and internship in pediatrics at the University of Connecticut-Connecticut Children's Medical Center followed by a fellowship in pediatric hematology-oncology at UPMC Children's Hospital. Dr. Cooper also earned his master's of science in clinical research at the University of Pittsburgh Institute for Clinical Research Education. In his role as clinical director of the Coagulation Program, Dr. Cooper cares for children with bleeding disorders and thrombosis concerns. As part of that mission, Dr. Cooper and Dr. Tahniat Syed of Adolescent Medicine co-lead a dedicated clinic for young women with menstrual disorders, known as the CHAMP (Comprehensive Hematologic Assessment of Adolescents with Menstrual Problems) Clinic. In addition to coagulation disorders, Dr. Cooper also cares for children with a variety of oncologic and other hematologic problems. Dr. Cooper’s research interests include thrombosis rates in adolescents and young adults versus younger children with cancer and the cost effectiveness of laboratory analysis of clotting disorders in children. He is a member of the American Society of Pediatric Hematology and Oncology, the American Society of Hematology, the Children’s Oncology Group, the Critical Mass Young Adult Alliance, the American Thrombosis & Hemostasis Network, the American Academy of Pediatrics, the Foundation for Women and Girls with Bleeding Disorders, and the Hemostasis and Thrombosis Research Society. View the full list of Dr. Cooper’s publications on PubMed. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Hemophilia A, and Blood Clots.

View the full list of Dr. Rapkin's publications on PubMed. Dr. Rapkin is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Rhabdoid Tumor, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Moses Raj is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Raj is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Lung Adenocarcinoma, and EGFR Positive Lung Cancer.

Steven Fein, MD, specializes in hematology oncology and is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine by the American Board of Internal Medicine. He practices at University of Pittsburgh Physicians, Department of Hematology Oncology. Dr. Fein completed his fellowship at University of Miami Miller School of Medicine at Jackson Memorial Hospital, residency at Duke University Medical Center, and medical education at Johns Hopkins University School of Medicine. Dr. Fein is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Olubusola Oluwole, MD, specializes in benign hematology and is board certified in hematology and internal medicine by the American Board of Internal Medicine. She practices at Benign Hematology and is affiliated with UPMC Magee-Womens Hospital, UPMC Shadyside, and UPMC Presbyterian. Dr. Oluwole completed her fellowship at University of Washington School of Medicine and residency and medical education at University of Pittsburgh School of Medicine. Dr. Oluwole is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Sriya Gunawardena is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Gunawardena is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Blood Clots, Hemophilia A, Anemia, and Hemolytic Anemia.

Margaret Ragni is a Hematologist in Pittsburgh, Pennsylvania. Dr. Ragni is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Hemophilia A, Blood Clots, Von Willebrand Disease (VWD), Hemophilia B, and Hip Replacement.

Joseph Kiss is a Hematologist in Pittsburgh, Pennsylvania. Dr. Kiss is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Thrombotic Thrombocytopenic Purpura, Hemolysis, Thrombocytopenia, and Anemia.

Mounzer Agha is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Agha is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Agha is currently accepting new patients.

Rafic Farah is an Oncologist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Farah is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Helen Analo is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Analo is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Ida Tuwatananurak is a primary care provider, practicing in Family Medicine in Pittsburgh, Pennsylvania. Dr. Tuwatananurak is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Obesity in Children, Food Allergy, Vitamin D Deficiency, and Bacterial Gastroenteritis.

Elana Bloom is a Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Bloom is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Febrile Neutropenia, Heyde Syndrome, Von Willebrand Disease (VWD), and Hereditary Resistance to Anti-Vitamin K.

Margaret Martin, MD, specializes in family medicine and is certified by the American Board of Family Medicine. She practices at Renaissance Family Practice-UPMC and is affiliated with UPMC St. Margaret. She completed her residency at UPMC St. Margaret Family Medicine Residency Program and her medical degree at St. George's University School of Medicine. Dr. Martin is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Familial Colorectal Cancer, Hypothyroidism, Hyperlipidemia Type 3, and Glucocorticoid-Remediable Aldosteronism.